Nyberg J - Search Results

1

Optimization of the intravenous glucose tolerance test in T2DM patients using optimal experimental design.

Silber HE, Nyberg J, Hooker AC, Karlsson MO. Silber HE, et al. Among authors: nyberg j. J Pharmacokinet Pharmacodyn. 2009 Jun;36(3):281-95. doi: 10.1007/s10928-009-9123-y. Epub 2009 Jun 25. J Pharmacokinet Pharmacodyn. 2009. PMID: 19554431

2

The lasso--a novel method for predictive covariate model building in nonlinear mixed effects models.

Ribbing J, Nyberg J, Caster O, Jonsson EN. Ribbing J, et al. Among authors: nyberg j. J Pharmacokinet Pharmacodyn. 2007 Aug;34(4):485-517. doi: 10.1007/s10928-007-9057-1. Epub 2007 May 22. J Pharmacokinet Pharmacodyn. 2007. PMID: 17516152

3

Trial treatment length optimization with an emphasis on disease progression studies.

Hennig S, Nyberg J, Hooker AC, Karlsson MO. Hennig S, et al. Among authors: nyberg j. J Clin Pharmacol. 2009 Mar;49(3):323-35. doi: 10.1177/0091270008329560. J Clin Pharmacol. 2009. PMID: 19246730

4

Simultaneous optimal experimental design on dose and sample times.

Nyberg J, Karlsson MO, Hooker AC. Nyberg J, et al. J Pharmacokinet Pharmacodyn. 2009 Apr;36(2):125-45. doi: 10.1007/s10928-009-9114-z. Epub 2009 Mar 25. J Pharmacokinet Pharmacodyn. 2009. PMID: 19319484

5

Adaptive-optimal design in PET occupancy studies.

Zamuner S, Di Iorio VL, Nyberg J, Gunn RN, Cunningham VJ, Gomeni R, Hooker AC. Zamuner S, et al. Among authors: nyberg j. Clin Pharmacol Ther. 2010 May;87(5):563-71. doi: 10.1038/clpt.2010.9. Epub 2010 Mar 24. Clin Pharmacol Ther. 2010. PMID: 20336064

6

Ethically attractive dose-finding designs for drugs with a narrow therapeutic index.

Lledó-García R, Hennig S, Nyberg J, Hooker AC, Karlsson MO. Lledó-García R, et al. Among authors: nyberg j. J Clin Pharmacol. 2012 Jan;52(1):29-38. doi: 10.1177/0091270010390041. Epub 2011 Jan 12. J Clin Pharmacol. 2012. PMID: 21228403

7

Optimal experimental design for assessment of enzyme kinetics in a drug discovery screening environment.

Sjögren E, Nyberg J, Magnusson MO, Lennernäs H, Hooker A, Bredberg U. Sjögren E, et al. Among authors: nyberg j. Drug Metab Dispos. 2011 May;39(5):858-63. doi: 10.1124/dmd.110.037309. Epub 2011 Feb 2. Drug Metab Dispos. 2011. PMID: 21289074

8

Application of the optimal design approach to improve a pretransplant drug dose finding design for ciclosporin.

Hennig S, Nyberg J, Fanta S, Backman JT, Hoppu K, Hooker AC, Karlsson MO. Hennig S, et al. Among authors: nyberg j. J Clin Pharmacol. 2012 Mar;52(3):347-60. doi: 10.1177/0091270010397731. Epub 2011 May 4. J Clin Pharmacol. 2012. PMID: 21543664

9

Optimal design in population kinetic experiments by set-valued methods.

Gennemark P, Danis A, Nyberg J, Hooker AC, Tucker W. Gennemark P, et al. Among authors: nyberg j. AAPS J. 2011 Dec;13(4):495-507. doi: 10.1208/s12248-011-9291-8. Epub 2011 Jul 15. AAPS J. 2011. PMID: 21761248 Free PMC article.

10

Rapid sample size calculations for a defined likelihood ratio test-based power in mixed-effects models.

Vong C, Bergstrand M, Nyberg J, Karlsson MO. Vong C, et al. Among authors: nyberg j. AAPS J. 2012 Jun;14(2):176-86. doi: 10.1208/s12248-012-9327-8. Epub 2012 Feb 17. AAPS J. 2012. PMID: 22350626 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

195 results

Search Page

Filters